MARKHAM, ON, May 9, 2013 /CNW/ - ALS Canada is amplifying its efforts to find a cure and offer the best support for
Canadians with amyotrophic lateral sclerosis (ALS). Six new board
members, with a breadth of experience in finance, education and
research, will guide the organization in minimizing the hardships
caused by ALS.
"Our organization continues to grow and make positive changes for people
living with the devastating disease," said Lanny McInnes, Chair, ALS
Canada. "Canadians affected by ALS face significant burdens physically,
emotionally and financially. We welcome our new board members in our
fight to ease these burdens."
ALS is a rapidly degenerative disease with no cure and limited treatment
options. It is commonly known as Lou Gehrig's disease. ALS Canada is
the only non-profit dedicated solely to fight ALS and strives to
improve the quality of life for people with the disease.
About the new board members
Josette Melanson is the VP Finance, Planning and Analysis for Sun Life
Financial. Before joining Sun Life Financial, Melanson held various
positions at multinational pharmaceutical companies. She brings
extensive pharmaceutical industry experience and in-depth knowledge of
finance governance, planning and analysis, as well as system
Dyana McLellan is Counsel to the National Managing Partner of Borden
Ladner Gervais LLP. She has ten years of experience in corporate
finance, mergers and acquisitions and corporate governance matters.
McLellan lost her father to ALS in 2004 and has since become an avid
supporter of the ALS community.
Jane Williamson is a Chartered Professional Accountant and is a Senior
Director, Inspections with the Canadian Public Accountability Board.
Williamson's experience and expertise in finance will provide strong
guidance to ALS Canada.
Dr. Lorne Zinman, MS, MD, FRCPC, M.Sc.
Dr. Lorne Zinman is the Medical Director of the ALS/Neuromuscular Clinic
at the Sunnybrook Health Sciences Centre. His team at the Sunnybrook
Research Institute aims to learn more about the disease's
pathophysiology to assist in the development of novel therapeutic
targets. His extensive experience in ALS research will be of great
As President of Temerity Inc., Moore helps companies solve business
challenges through management expertise and private equity investment.
She has a solid foundation in demanding entrepreneurial environments
requiring diverse skills in strategy, negotiations, communications,
marketing and brand management. Moore's cousin was diagnosed with ALS
five years ago. She has an intimate understanding of the need for
research and the challenges associated with ALS.
Melanie York has devoted herself to the education and entertainment of
youth. As executive producer for Corus Entertainment at YTV, Melanie
produced award-winning anti-bullying campaigns, half-hour specials with
UNICEF documenting the rights of the child, and multi-platform
interactive programming for youth. York was diagnosed with ALS in 2008.
Since then, her need to communicate, create and contribute has not
wavered. She currently chairs the ALS support group at Sunnybrook
About the board of directors
ALS Canada's board of directors provides vital guidance to the
organization. In 2012, the transition board successfully reconstructed
the old model of two organizations in Ontario to build an entirely new
and cohesive organization. Genevieve Bertrand, Graeme Imrie, Lanny
McInnes, Michael Gardner, Pierre Thibodeau and Heather Durham will
continue to serve on the board. In addition, Cathy Martin, co-chair of
the Federation Council, and Nigel Van Loan, chair of the Client
Services Council, will continue to sit. Together the board works with a
spirit of cooperation, care, compassion, collaboration, controls and a
Canada-wide focus to achieve a stronger, integrated organization.
SOURCE: ALS Canada
For further information: